ConductScience.org, home

Trial · NCT06575647

Vivax Elimination With Tafenoquine (VET) Study

NCT06575647, Phase 4, Completed, Shoklo Malaria Research Unit

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Vivax Elimination With Tafenoquine (VET) Study. Trials, record NCT06575647. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06575647

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Vivax Elimination With Tafenoquine (VET) Study
NCT number
NCT06575647
Status
Completed
Phases
Phase 4
Enrollment
1,242 participants, actual
Lead sponsor
Shoklo Malaria Research Unit
Conditions
Malaria, Malaria, Vivax, Plasmodium Vivax, Plasmodium Vivax Malaria
Interventions
Tafenoquine
First posted
2024-08-28
Last updated
2026-01-06

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Serious Adverse Events (SAEs) to assess safety and tolerability of Tafenoquine MDABaseline survey to end of Month-1 surveyNumber of (serious) adverse events reported
SecondaryTo compare the incidence by Rapid Diagnostic Test (RDT) of P. vivax before and 1-3-6 months after providing the single round of MDA with Tafenoquine radical cure treatmentMonth 1, 3 and 6Malaria Incidence by RDT reported from malaria post at month 1, 3 and 6
SecondaryTo evaluate the adherence of healthcare workers to the SOP for implementing MDA of Tafenoquine.Baseline survey and Month-1 surveyProportion of village health workers adhere to the SOP for G6PD testing \& documentation, tafenoquine administration and adverse event recording \& reporting.
SecondaryTo compare the prevalence by PCR of P. vivax before and a month after providing the single round of MDA.Baseline survey and Month-1 surveyDifference in proportion positive to PCR positive before and a month after providing the single round of MDA.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
22531245RESULTPubMed
23212366RESULTPubMed
29398388RESULTPubMed
30698522RESULTPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06575647

GET https://conductscience.org/api/trials/v1/NCT06575647/registered